Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years

JH Estepp, R Kalpatthi, G Woods… - Pediatric blood & …, 2022 - Wiley Online Library
Background Sickle cell disease (SCD) is a devastating, multisystemic disorder that affects
millions of people worldwide. The earliest clinical manifestations of SCD can affect infants as …

Indications for transfusion in the management of sickle cell disease

H Han, L Hensch, VN Tubman - Hematology, 2021 - ashpublications.org
The transfusion of red blood cells (RBCs) is a crucial treatment for sickle cell disease (SCD).
While often beneficial, the frequent use of transfusions is associated with numerous …

[HTML][HTML] Advances in the diagnosis and treatment of sickle cell disease

AM Brandow, RI Liem - Journal of Hematology & Oncology, 2022 - Springer
Sickle cell disease (SCD), which affects approximately 100,000 individuals in the USA and
more than 3 million worldwide, is caused by mutations in the βb globin gene that result in …

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial

SU Abdullahi, S Sunusi, MS Abba, S Sani, HA Inuwa… - Blood, 2023 - ashpublications.org
We tested the hypothesis that fixed oral moderate-dose hydroxyurea (20 mg/kg per day) for
initial treatment of secondary stroke prevention results in an 80% relative risk reduction of …

Health related quality of life in children with sickle cell disease: A systematic review and meta-analysis

M Stokoe, HM Zwicker, C Forbes, NELH Abu-Saris… - Blood reviews, 2022 - Elsevier
This review had three aims: 1) describe the measures used to assess health-related quality
of life (HRQL) in pediatric patients diagnosed with sickle cell disease (SCD); 2) document …

[HTML][HTML] Advances in the diagnosis and treatment of pediatric arterial ischemic stroke

LR Sun, JK Lynch - Neurotherapeutics, 2023 - Elsevier
Though rare, stroke in infants and children is an important cause of mortality and chronic
morbidity in the pediatric population. Neuroimaging advances and implementation of …

[HTML][HTML] Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: final results of the SPIN trial

NA Galadanci, SU Abdullahi, SA Abubakar… - American journal of …, 2020 - ncbi.nlm.nih.gov
In children with sickle cell anemia (SCA) living in high-income set-tings, the routine use of
transcranial Doppler (TCD) measurements, coupled with monthly blood transfusion therapy …

The evolving treatment landscape for children with sickle cell disease

SA Jacob, R Talati, J Kanter - The Lancet Child & Adolescent Health, 2023 - thelancet.com
Sickle cell disease is the most common inherited pathological haemoglobinopathy. Over the
past 30 years, disease-related morbidity and mortality have improved in high-income …

[HTML][HTML] Application of transcranial Doppler in cerebrovascular diseases

Y Wan, X Teng, S Li, Y Yang - Frontiers in Aging Neuroscience, 2022 - frontiersin.org
Transcranial Doppler (TCD) is a rapid and non-invasive diagnostic technique that can
provide real-time measurements of the relative changes in cerebral blood velocity (CBV) …

[HTML][HTML] Cognitive impairment in primary and secondary headache disorders

O Begasse de Dhaem, MS Robbins - Current Pain and Headache Reports, 2022 - Springer
Abstract Purpose of Review To critically evaluate the recent literature on cognitive
impairment and headache. Recent Findings Neurocognitive symptoms are prevalent …